Sensyne interims ‘disappointing’ but position group for future growth

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Sensyne Health said its latest interim results were disappointing after revenue more than halved to £1min the six months ended 31 October 2021. The clinical AI company, which announced the completion of a £11.4m fundraise on 26 January, said it had been a challenging period, which ‘tested the commitment and resilience’ of the group, its staff and stakeholders. Revenue primarily derived…

You must be a HM Subscriber to view this content.

Subscribe Now »